July 18, 2025

Can Use of Aprepitant During Chemotherapy Improve Triple-Negative Breast Cancer Outcomes?

A commonly used antiemetic may help to improve patient outcomes when given during chemotherapy treatment for women with early triple-negative breast cancer, study findings suggest.

The ASCO Post

July 17, 2025

Medical Physics Residency Program Preps Future Generation of Experts

At Baptist Health Miami Cancer Institute, a team of 26 medical physicists partner with radiation oncologists to craft individualized treatment strategies that push the boundaries of what’s possible in radiation therapy.

Baptist Health South Florida

July 17, 2025

Study Reports Increasing Incidence Rates of Appendiceal Adenocarcinoma in Those Born After 1945

A recent study published in the Annals of Internal Medicine1 estimated incidence rates of appendiceal adenocarcinoma across birth cohorts in the United States. Andreana N. Holowatyj, PhD, MSCI, of Van...

The ASCO Post

July 17, 2025

Upfront Radical Cytoreductive Surgery Extends Progression-Free Survival in Advanced Ovarian Cancer

The TRUST trial is the first phase III randomized study to show improved progression-free survival for primary cytoreductive surgery compared with interval surgery without compromising short-term or l...

The ASCO Post

July 16, 2025

Inaugural Scholars Program at Boca Raton Regional Hospital Honors Three Marcus Neuroscience Institute Physicians

These Scholars, generously funded by the Marcus Foundation, Inc., are now able to learn more about the causes and treatment of disorders affecting the nervous system — not only from a scientific perspective but also by examining how society and systems contribute to these issues.

Baptist Health South Florida

July 15, 2025

Dana-Farber Research News 07.15.2025

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from June 16 through June 30.

Dana-Farber

July 15, 2025

Enhancing NSCLC Brain Metastasis Treatment With MR-Guided Ultrasound: Manmeet Ahluwalia, MD, MBA, FASCO

Combining magnetic resonance (MR)-guided focused ultrasound with microbubbles and immune checkpoint inhibitors (ICIs) could transform non-small cell lung cancer (NSCLC) treatment by reducing radiation side effects.

Baptist Health South Florida

July 14, 2025

Dual Menin and KAT6A/7 Inhibition Improves Outcomes in NUP98-Rearranged Pediatric AML Models

A combination of menin inhibition and KAT6A/7 inhibition significantly improved survival for pediatric acute myeloid leukemia (AML) in AML model systems, according to findings published in Cancer Disc...

The ASCO Post

July 14, 2025

Can Planned C-Sections Increase the Risk of Childhood ALL?

A study that included nearly 2.5 million children born in Sweden found the risk of ALL was 21% higher in children born by planned cesarean section (C-section) compared with children born vaginally, al...

The ASCO Post